Danton News Corner

Investors are always looking for information, market analysis or a hot tip to help them decide on their investments. There are a number of websites, like MSN Mooney, Google Finance, CNBC, and Ozrealestatenews.com that are dedicated to providing news and updates on the stock market. Investors can subscribe to publications like the Wall Street Journal and the Economist for information, or listen to Podcasts by the Motley Fool and other experts. If you are looking for news and information about stocks traded on the New York Stock Exchange, The American Stock Exchange, or the NASDQ, you have plenty of resources to help you make good investment decisions.

The penny stock market is considered to be a riskier investment than the traditional blue chip or officially listed stocks. Finding a reliable website or other source for updated penny stock news can be a challenge. Once you have found a source or site that you trust you should use those tools to help you pick penny stocks and manage your investment portfolio.

More info…
Marine Essentials launches Green Tea Extract With Concentrated Fish Oil. Weight Loss
Study: Green Tea with Fish Oil Combination Can Accelerate Weight Loss by Over 300%.

More info…
SUMMARY: The battle for more customers has moved online, where business owners must fight to stay alive despite not being armed with a dedicated social media marketing department. Until now, building a successful social media presence was a true challenge. Launching May 14, 2013, Emperor Social has created a turnkey solution that helps business owners easily build a professional-looking Facebook fan page that attracts new potential customers in droves all without hiring a designer or designated social media manager.

More info…
San Antonio sports podiatrist, Dr. Ed Davis of South Texas Podiatry stated today in an email to his clients, that the injury Kobe Bryant received to his Achilles tendon may have been a preventable injury.

More info…
Bio-Path Holdings Inc., (OTCQX: BPTH) (Bio-Path), a research and development company for cancer treatment, recently announced that its first two initial drug candidates have a market potential of more than $4 billion. With its recent value set at $0.35 a share and currently rising with a $22 million market cap, Bio-Path officials state they are poised for significant growth in 2013.